/
J Med Chem
From pyrazolones to azaindoles: evolution of active-site SHP2 inhibitors based on scaffold hopping and bioisosteric replacement
- Y. Mostinski
- G.J.J.E. Heynen
- M.P. López-Alberca
- J. Paul
- S. Miksche
- S. Radetzki
- D. Schaller
- E. Shanina
- C. Seyffarth
- Y. Kolomeets
- N. Ziebart
- J. de Schryver
- S. Oestreich
- M. Neuenschwander
- Y. Roske
- U. Heinemann
- C. Rademacher
- A. Volkamer
- J.P. von Kries
- W. Birchmeier
- M. Nazaré